Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 3,148 Shares of Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 3,148 shares of Phreesia stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total transaction of $73,191.00. Following the sale, the chief operating officer now owns 755,719 shares in the company, valued at $17,570,466.75. The sale was disclosed in a document filed with the SEC, which is available through this link.

Evan Roberts also recently made the following trade(s):

• On Tuesday, July 16th, Evan Roberts sold 1,669 shares of Phreesia stock. The stock was sold at an average price of $23.74, for a total value of $39,622.06.

Phreesia Stock Performance

Shares of PHR opened at $23.76 on Friday. Phreesia, Inc. has a 1 year low of $12.05 and a 1 year high of $29.16. The company’s 50 day simple moving average is $23.63 and its 200 day simple moving average is $22.75. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77.

Wall Street Analyst Weigh In

PHR has been the subject of several research reports. JPMorgan Chase & Co. upped their price target on shares of Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Monday. Royal Bank of Canada reissued a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a report on Thursday, September 5th. Robert W. Baird boosted their price target on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a research note on Friday, September 6th. Truist Financial boosted their price objective on shares of Phreesia from $29.00 to $31.00 and gave the stock a “buy” rating in a research report on Friday, September 6th. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $34.00 price target on shares of Phreesia in a research report on Thursday, September 5th. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, Phreesia currently has an average rating of “Moderate Buy” and an average target price of $29.42.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of PHR. nVerses Capital LLC increased its stake in shares of Phreesia by 76.5% during the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock valued at $64,000 after acquiring an additional 1,300 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in Phreesia by 5,462.3% in the fourth quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock valued at $89,000 after purchasing an additional 3,769 shares during the period. EntryPoint Capital LLC purchased a new stake in Phreesia in the first quarter valued at approximately $169,000. Quadrature Capital Ltd acquired a new position in Phreesia during the first quarter worth approximately $202,000. Finally, Lombard Odier Asset Management USA Corp purchased a new position in Phreesia during the second quarter worth approximately $202,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.